Immunologic quantification of carcinogen-DNA adducts

Area of Science:

• Immunology
• Toxicology
• Molecular Biology

Background:

• Sensitive immunological methods for detecting carcinogen-DNA adducts are crucial for monitoring environmental carcinogen exposure in human populations.
• Measuring the biologically effective dose in humans can help identify carcinogenic hazards and refine risk assessments.

Purpose of the Study:

• To develop and characterize monoclonal antibodies for specific carcinogen-DNA adducts.
• To assess the utility of these antibodies in detecting exposure to environmental carcinogens.

Main Methods:

• Development of monoclonal antibodies against DNA modified by benzo[a]pyrene diol epoxide (BPDE-I), 1-aminopyrene (1-AP), and 8-methoxypsoralen (8-MOP).
• Immunization of BALB/cCr mice with modified DNA-methylated bovine serum albumin complexes.
• Characterization of antibody specificity and cross-reactivity using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Highly specific monoclonal antibodies were generated for BPDE-I-DNA, 1-AP-DNA, and 8-MOP-DNA, showing no cross-reactivity with nonmodified DNA.
• Antibodies to BPDE-I-DNA exhibited cross-reactivity with similar diol epoxides of benz[a]anthracene and chrysene, recognizing N-2 of guanine adducts.
• Antibodies to 1-AP-DNA showed cross-reactivity with nitro-aminopyrene derivatives and limited cross-reactivity with BPDE-I-DNA and acetylaminofluorene-DNA.

Conclusions:

• Developed specific monoclonal antibodies are valuable tools for detecting carcinogen-DNA adducts.
• These antibodies can aid in screening human populations for exposure to specific environmental carcinogens.
• The specificity profile of the antibodies provides insights into the recognition of carcinogen-DNA adduct structures.